<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240713062416N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-18</date_registration>
      <primary_sponsor>Islamic Azad University Semnan branch</primary_sponsor>
      <public_title>Effectiveness of repeated transcranial magnetic stimulation on sleep quality, emotional disturbance and severity of disorder symptoms in patients with emotional disorders</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of repeated transcranial magnetic stimulation on sleep quality, emotional disturbance and severity of disorder symptoms in patients with emotional disorders</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-07-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77957</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, patients are randomly assigned to intervention and control groups using the random block method. First, a number is assigned to each sample person. Then the numbers are written on paper, folded and thrown into a container. The papers are thoroughly mixed and removed one by one. Accordingly, one number is assigned to the first group and one number to the second group. For randomized use, one group is known as the "control group" and the other group is known as the "intervention group" by drawing lots. To randomly determine "control group" and "intervention group", we put the set of numbers of each group in two separate envelopes and put these envelopes in a container. Then we randomly take one envelope out of the container and assign it to the "intervention group" and the other envelope to the "control group". This method ensures that the allocation of patients to groups is done completely randomly and without bias, Blinding description: Because the patients do not know about the group assignment, the study is performed in a blinded manner.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Behavioral and emotional disorders.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This research will be conducted on patients with emotional disorders and the intervention will include 20 sessions (regularly on 5 days of the week). The experimental group was treated with transcranial magnetic stimulation from the usual protocol used in clinics, which includes a frequency of 10 Hz, a duration of stimulation of 5 seconds, an interval between each stimulation of 25 seconds, 120% movement threshold, and a stimulation location equal to f3 area in the 10-20 system. or LDLPFC and the duration of stimulation is 20 minutes. Intervention 2: Control group: They will receive rTMS in a silent mode.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Since the research plan is related to a thesis, only the study protocol, clinical study report, and study results will be published. The participant data file contains information about the participants, and due to the preservation of individuals' privacy it cannot be published.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Sohrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5th floor, No. 5, East Second Alley, Akakia Street, Mobarez East Street, Abu Dharr Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1778833386</zip>
        <telephone>+98 21 3364 5489</telephone>
        <email>fsohrabi.master@gmail.com</email>
        <affiliation>Islamic Azad University Semnan branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Izadi Mazidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University, University Town, Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513137111</zip>
        <telephone>+98 23 3365 4040</telephone>
        <email>maryam.izadi.psy@gmail.com</email>
        <affiliation>Islamic Azad University Semnan branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients must be certified by a psychiatrist or psychologist based on DSM-5 or ICD-10 diagnostic criteria.
The age range of participants should be between 18 and 65 years.
Patients must have moderate to severe symptom severity as assessed using validated instruments such as the Beck Depression Scale (BDI), Hamilton Anxiety Scale (HAM-A), or similar instruments.
Patients must sign informed consent and be willing to participate in all repeated transcranial magnetic stimulation sessions and related assessments.
Patients who are currently receiving medication or psychotherapy should have stable treatment and not have any major changes in their treatment for at least 4 weeks before the start of the study.
Patients must have significant problems in sleep quality and emotional disturbances that affect their quality of life and daily performance.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients diagnosed with other psychiatric disorders such as psychotic disorders, bipolar disorders or substance abuse disorders in the period of 6 months before the start of the study.
Taking medications that may interfere with transcranial magnetic stimulation, such as anticonvulsants or antipsychotics.
Patients with serious physical problems such as cardiovascular disease, renal or hepatic failure, or serious neurological disease that may interfere with the treatment protocol.
Patients with metal implants in the head or neck area (such as implanted hearing aids) that may be stimulated by magnetic fields.
Pregnant or lactating women due to unknown risks to the fetus or infant.
Patients who do not attend or follow instructions for repeated transcranial magnetic stimulation sessions or follow-up assessments.
Patients who decide to withdraw from the study at any stage of the research and do not want to continue.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F98</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This research will be conducted on patients with emotional disorders and the intervention will include 20 sessions (regularly on 5 days of the week). The experimental group was treated with transcranial magnetic stimulation from the usual protocol used in clinics, which includes a frequency of 10 Hz, a duration of stimulation of 5 seconds, an interval between each stimulation of 25 seconds, 120% movement threshold, and a stimulation location equal to f3 area in the 10-20 system. or LDLPFC and the duration of stimulation is 20 minutes.</i_keyword>
      <i_keyword>Control group: They will receive rTMS in a silent mode.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep quality. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Pittsburgh Sleep Quality Questionnaire (PSQI).</prim_outcome>
      <prim_outcome>Emotional disturbance. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Emotional disturbance questionnaire (DASS21).</prim_outcome>
      <prim_outcome>Severity of disorder symptoms. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Clinical General Impression Questionnaire (CGI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University Semnan branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-05-21</approval_date>
        <contact_name>Ethics committee of Semnan Azad University</contact_name>
        <contact_address>Islamic Azad University, University Town, Semnan, Iran Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
